Found 4374 articles for: ""
Tolerability Comparison of Adapalene Gel, 0.3% versus Tazarotene Cream, 0.05% in Subjects with Healthy Skin
June 2007 | Volume 6 | Issue 6 | Original Article | 632 | Copyright © June 2007
Background: Topical retinoids, including adapalene and tazarotene, are a primary treatment choice for patients with acne. Adapalene is currently marketed in a 0.1% concentration in gel and cream form...
Read MoreA Comparative Review of the Efficacy and Tolerability of Retinoid-Containing Combination Regimens for the Treatment of Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 625 | Copyright © June 2007
Many physicians regularly prescribe combination therapy involving a retinoid for their acne patients. The most common retinoid-containing regimens include either oral antibiotics or topical benzoyl p...
Read MoreStudy Results of Benzoyl Peroxide 5%/Clindamycin 1% Topical Gel, Adapalene 0.1% Gel and Use in Combination for Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 616 | Copyright © June 2007
Combination therapy is the standard of care in the management of acne vulgaris. It is essential to treat as many aspects of acne pathogenesis as possible. Due to increasing insensitivity of Propi...
Read MoreClinical Safety and Efficacy Studies of a Novel Formulation Combining 1.2% Clindamycin Phosphate and 0.025% Tretinoin and for the Treatment of Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 607 | Copyright © June 2007
Clindamycin phosphate 1.2% and tretinoin 0.025% gel (CLIN/RA gel [ZIANA™ Gel]) is a novel topical combination agent approved by the FDA for the treatment of acne vulgaris in patients 12 years of ag...
Read MoreA Closer Look at Truncal Acne Vulgaris: Prevalence, Severity, and Clinical Significance
June 2007 | Volume 6 | Issue 6 | Original Article | 597 | Copyright © June 2007
Data is very limited on the demographics, epidemiology, grading, and management of truncal acne vulgaris. In this study completed in 5 cities across the US, 696 patients were assessed to evaluate the...
Read MorePediatric Acne: Clinical Presentations, Evaluation, and Management
June 2007 | Volume 6 | Issue 6 | Original Article | 589 | Copyright © June 2007
Acne vulgaris can be easy to diagnose yet difficult to evaluate and manage, especially when it presents in infancy and childhood. The differential diagnosis of acne varies by age and, in some cases, ...
Read MoreThe Propionibacterium acnes Genome: From the Laboratory to the Clinic
June 2007 | Volume 6 | Issue 6 | Original Article | 582 | Copyright © June 2007
The genome of Propionibacterium acnes, the microbe presumed to be at least partially etiologic for the development of acne, has recently been decoded. The genome supports long-standing concepts regar...
Read MoreClinical Trial Review
March 2007 | Volume 6 | Issue 3 | Features | 356 | Copyright © March 2007
Schools Of Pharmacology
March 2007 | Volume 6 | Issue 3 | Features | 352 | Copyright © March 2007
Pipeline Previews
March 2007 | Volume 6 | Issue 3 | Features | 350 | Copyright © March 2007
Washington Whispers
March 2007 | Volume 6 | Issue 3 | Features | 346 | Copyright © March 2007
Surgical Pearl: Nokor Needle Marking - A Simple Method to Maintain Orientation During Subcision
March 2007 | Volume 6 | Issue 3 | Features | 343 | Copyright © March 2007
Treatment of Pityriasis Rubra Pilaris with Pimecrolimus Cream 1%
March 2007 | Volume 6 | Issue 3 | Case Reports | 340 | Copyright © March 2007
Pityriasis rubra pillaris is an uncommon idiopathic dermatosis considered both a keratinization and an inflammatory disorder. Treatment is largely based on the information presented in case reports. ...
Read MoreClinical Improvement of Pityriasis Rubra Pilaris with Efalizumab in a Pediatric Patient
March 2007 | Volume 6 | Issue 3 | Case Reports | 337 | Copyright © March 2007
Pityriasis rubra pilaris has no single effective therapy and there are some cases resistant to multiple treatments. Psoriasis has clinical and therapeutic response overlaps with pityriasis rubra pila...
Read MorePersistent Erythema Multiforme and CMV Infection
March 2007 | Volume 6 | Issue 3 | Case Reports | 333 | Copyright © March 2007
Persistent erythema multiforme is a rare disorder with only 23 known cases reported in the literature. Persistent erythema multiforme has been reported in association with Epstein-Barr virus, herpes ...
Read MoreEosinophilic Granuloma of the Skin: Response to Intralesional Corticosteroid Injection
March 2007 | Volume 6 | Issue 3 | Case Reports | 329 | Copyright © March 2007
Langerhans cell histiocytosis (LCH) is a histiocytic disorder in which the Langerhans cell is arrested in a premature, partially active state. The disease comprises a spectrum of disorders, the most ...
Read MoreDelayed Presentation of Impending Necrosis following Soft Tissue Augmentation with Hyaluronic Acid and Successful Management with Hyaluronidase
March 2007 | Volume 6 | Issue 3 | Case Reports | 325 | Copyright © March 2007
Soft tissue augmentation is a key element in the successful management of facial rhytids and scars. Injection of hyaluronic acid gels into the dermis is generally well-tolerated with only minimal sid...
Read MoreTreatment of Moderate to Severe Inflammatory Acne Vulgaris: Photodynamic Therapy with 5-Aminolevulinic Acid and a Novel Advanced Fluorescence Technology Pulsed Light Source
March 2007 | Volume 6 | Issue 3 | Original Article | 319 | Copyright © March 2007
The use of photodynamic therapy (PDT) with 20% 5-aminolevulinic acid (ALA) for the treatment of acne vulgaris has been explored. This study evaluates the safety and efficacy of a new Advanced Fluores...
Read MoreA Single-Center, Open-Label, Prospective Pilot Study of Subcutaneous Efalizumab for Oral Erosive Lichen Planus
March 2007 | Volume 6 | Issue 3 | Original Article | 310 | Copyright © March 2007
Objective: To evaluate the efficacy of efalizumab in the treatment of oral erosive lichen planus. Design: A single-center, open-label, prospective pilot study. The primary efficacy outcome measure wa...
Read MoreReductions in Healthcare Resource Utilization in Psoriatic Arthritis Patients Receiving Etanercept Therapy: Results from the EDUCATE Trial
March 2007 | Volume 6 | Issue 3 | Original Article | 299 | Copyright © March 2007
The Experience Diagnosing, Understanding Care, and Treatment with Enbrel® (EDUCATE) trial is a phase IV, 24-week, multicenter, open-label study of etanercept 50 mg weekly in the treatment of psoriat...
Read More